Agreement between oncology guidelines and clinical practice in Italy: The 'right' program. A project of the Italian Association of Medical Oncology (AIOM)

Sandro Barni, M. Venturini, G. D. Beretta, S. Gori, A. Molino, C. Carnaghi, R. Labianca, S. Sgarbi, L. Simoni, E. Maiello

Research output: Contribution to journalArticle

Abstract

Background: RIGHT (R esearch for the I dentification of the most effective and h IG hly accepted clinical guidelines for the cancer T reatment) is a project promoted by the Italian Association of Medical Oncology (AIOM) to measure the concordance between oncology guidelines and clinical practice. The goal of this pilot phase was to develop and test a reliable process to measure this concordance nationwide. Materials and methods: Twenty Italian centers participated to the survey. Breast cancer (BC) and colorectal cancer (CRC): guidelines issued by AIOM in 2003 were selected. A total of 29 indicators linked to the process of care were abstracted. Patients who had their first visit at the oncology center between February 2004 and June 2005, with a diagnosis of invasive BC (stage 1 or 2), colon cancer (stage 3), rectal cancer (stage T3-4 or N1-2) or advanced CRC were enclosed. Results and conclusion: One hundred and sixty-one patients (80%) were analyzed. On average, 93% of BC and 80.3% of colorectal patients received recommended care. These first results indicate that the RIGHT system provides a valid measurement of oncology care to assess agreement with guidelines. A second larger phase of this nationwide monitoring program will enable results to be generalized.

Original languageEnglish
JournalAnnals of Oncology
Volume18
Issue numberSUPPL. 6
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Medical Oncology
Practice Guidelines
Italy
Guidelines
Breast Neoplasms
Colorectal Neoplasms
Process Assessment (Health Care)
Rectal Neoplasms
Colonic Neoplasms
Neoplasms

Keywords

  • Breast cancer
  • Colon cancer
  • Guidelines adherence
  • Italian guidelines
  • Process indicators

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Cancer Research

Cite this

Agreement between oncology guidelines and clinical practice in Italy : The 'right' program. A project of the Italian Association of Medical Oncology (AIOM). / Barni, Sandro; Venturini, M.; Beretta, G. D.; Gori, S.; Molino, A.; Carnaghi, C.; Labianca, R.; Sgarbi, S.; Simoni, L.; Maiello, E.

In: Annals of Oncology, Vol. 18, No. SUPPL. 6, 06.2007.

Research output: Contribution to journalArticle

Barni, Sandro ; Venturini, M. ; Beretta, G. D. ; Gori, S. ; Molino, A. ; Carnaghi, C. ; Labianca, R. ; Sgarbi, S. ; Simoni, L. ; Maiello, E. / Agreement between oncology guidelines and clinical practice in Italy : The 'right' program. A project of the Italian Association of Medical Oncology (AIOM). In: Annals of Oncology. 2007 ; Vol. 18, No. SUPPL. 6.
@article{b27b826b37e548f5b52baa8914e615f3,
title = "Agreement between oncology guidelines and clinical practice in Italy: The 'right' program. A project of the Italian Association of Medical Oncology (AIOM)",
abstract = "Background: RIGHT (R esearch for the I dentification of the most effective and h IG hly accepted clinical guidelines for the cancer T reatment) is a project promoted by the Italian Association of Medical Oncology (AIOM) to measure the concordance between oncology guidelines and clinical practice. The goal of this pilot phase was to develop and test a reliable process to measure this concordance nationwide. Materials and methods: Twenty Italian centers participated to the survey. Breast cancer (BC) and colorectal cancer (CRC): guidelines issued by AIOM in 2003 were selected. A total of 29 indicators linked to the process of care were abstracted. Patients who had their first visit at the oncology center between February 2004 and June 2005, with a diagnosis of invasive BC (stage 1 or 2), colon cancer (stage 3), rectal cancer (stage T3-4 or N1-2) or advanced CRC were enclosed. Results and conclusion: One hundred and sixty-one patients (80{\%}) were analyzed. On average, 93{\%} of BC and 80.3{\%} of colorectal patients received recommended care. These first results indicate that the RIGHT system provides a valid measurement of oncology care to assess agreement with guidelines. A second larger phase of this nationwide monitoring program will enable results to be generalized.",
keywords = "Breast cancer, Colon cancer, Guidelines adherence, Italian guidelines, Process indicators",
author = "Sandro Barni and M. Venturini and Beretta, {G. D.} and S. Gori and A. Molino and C. Carnaghi and R. Labianca and S. Sgarbi and L. Simoni and E. Maiello",
year = "2007",
month = "6",
doi = "10.1093/annonc/mdm252",
language = "English",
volume = "18",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "SUPPL. 6",

}

TY - JOUR

T1 - Agreement between oncology guidelines and clinical practice in Italy

T2 - The 'right' program. A project of the Italian Association of Medical Oncology (AIOM)

AU - Barni, Sandro

AU - Venturini, M.

AU - Beretta, G. D.

AU - Gori, S.

AU - Molino, A.

AU - Carnaghi, C.

AU - Labianca, R.

AU - Sgarbi, S.

AU - Simoni, L.

AU - Maiello, E.

PY - 2007/6

Y1 - 2007/6

N2 - Background: RIGHT (R esearch for the I dentification of the most effective and h IG hly accepted clinical guidelines for the cancer T reatment) is a project promoted by the Italian Association of Medical Oncology (AIOM) to measure the concordance between oncology guidelines and clinical practice. The goal of this pilot phase was to develop and test a reliable process to measure this concordance nationwide. Materials and methods: Twenty Italian centers participated to the survey. Breast cancer (BC) and colorectal cancer (CRC): guidelines issued by AIOM in 2003 were selected. A total of 29 indicators linked to the process of care were abstracted. Patients who had their first visit at the oncology center between February 2004 and June 2005, with a diagnosis of invasive BC (stage 1 or 2), colon cancer (stage 3), rectal cancer (stage T3-4 or N1-2) or advanced CRC were enclosed. Results and conclusion: One hundred and sixty-one patients (80%) were analyzed. On average, 93% of BC and 80.3% of colorectal patients received recommended care. These first results indicate that the RIGHT system provides a valid measurement of oncology care to assess agreement with guidelines. A second larger phase of this nationwide monitoring program will enable results to be generalized.

AB - Background: RIGHT (R esearch for the I dentification of the most effective and h IG hly accepted clinical guidelines for the cancer T reatment) is a project promoted by the Italian Association of Medical Oncology (AIOM) to measure the concordance between oncology guidelines and clinical practice. The goal of this pilot phase was to develop and test a reliable process to measure this concordance nationwide. Materials and methods: Twenty Italian centers participated to the survey. Breast cancer (BC) and colorectal cancer (CRC): guidelines issued by AIOM in 2003 were selected. A total of 29 indicators linked to the process of care were abstracted. Patients who had their first visit at the oncology center between February 2004 and June 2005, with a diagnosis of invasive BC (stage 1 or 2), colon cancer (stage 3), rectal cancer (stage T3-4 or N1-2) or advanced CRC were enclosed. Results and conclusion: One hundred and sixty-one patients (80%) were analyzed. On average, 93% of BC and 80.3% of colorectal patients received recommended care. These first results indicate that the RIGHT system provides a valid measurement of oncology care to assess agreement with guidelines. A second larger phase of this nationwide monitoring program will enable results to be generalized.

KW - Breast cancer

KW - Colon cancer

KW - Guidelines adherence

KW - Italian guidelines

KW - Process indicators

UR - http://www.scopus.com/inward/record.url?scp=35748981226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35748981226&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdm252

DO - 10.1093/annonc/mdm252

M3 - Article

C2 - 17591818

AN - SCOPUS:35748981226

VL - 18

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL. 6

ER -